Sira Medical has been given the green light by the US Food and Drug Administration (FDA) for the rollout of its new service, an AR preoperative surgical planning application.

The service aids clinicians by providing higher-quality imaging, which can be vital for making patient management decisions. The company points to several benefits of this application based on peer-reviewed studies, which include time saved during operations and a preference for AR models in surgical planning. 

Sira Medical offers AR software for medical imaging, which is applicable for clinicians, patients, and students to visualize human anatomy. Its platform can be accessed via Microsoft’s HoloLens headset or a smartphone. Apart from surgical planning, the models on the platform can be used to complement existing curricula for academia. 

Analyst QuickTake: The FDA approval follows the company’s invitation to NVIDIA’s Inception Program in March 2020, which sought to incorporate machine-learning capabilities for surgical planning. Further, studies indicate that Sira Medical’s platform is as accurate as a standard CT scan.